Cipla’s promoters have sold a 2.53 per cent stake in the company for the purpose of creating liquidity. Certain company promoters sold 2,04,50,375 shares on May 15, 2024. Post transaction, the entire promoter group continues to hold 31.67 per cent in the company and remains committed to the future of Cipla.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.